StockData
Incannex Healthcare Inc. logo

Incannex Healthcare Inc. (IXHL) stock

IXHLNasdaqPharmaceutical PreparationsFiscal year ends June 30
Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30
$1.74−0.19 (-9.84%)

Close on Nov 17, 2026Market cap $21.83MP/E –Yield –

Incannex Healthcare operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Incannex Healthcare's operating cash flow for the twelve months ending Sep 30, 2026 was -$3.18M. For fiscal 2026 it was -$12.87M. The highest annual figure on record is -$3.91M in fiscal 2020.

Annual operating cash flow

PeriodPeriod endValueChange
FY2026Jun 30, 2026-$12.87M–
FY2025Jun 30, 2025-$12.51M–
FY2024Jun 30, 2024-$15.85M–
FY2023Jun 30, 2023-$10.75M–
FY2022Jun 30, 2022-$12.81M–
FY2021Jun 30, 2021-$6.91M–
FY2020Jun 30, 2020-$3.91M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ3 2026Sep 30, 2026$521.00K–
Q4 FY2026CQ2 2026Jun 30, 2026$3.37M–
Q3 FY2026CQ1 2026Mar 31, 2026-$2.46M–
Q2 FY2026CQ4 2025Dec 31, 2025-$4.62M–
Q1 FY2026CQ3 2025Sep 30, 2025-$9.16M–
Q4 FY2025CQ2 2025Jun 30, 2025-$1.48M–
Q3 FY2025CQ1 2025Mar 31, 2025-$3.16M–
Q2 FY2025CQ4 2024Dec 31, 2024-$5.63M–
Q1 FY2025CQ3 2024Sep 30, 2024-$2.25M–
Q4 FY2024CQ2 2024Jun 30, 2024-$3.64M–
Q3 FY2024CQ1 2024Mar 31, 2024-$4.35M–
Q2 FY2024CQ4 2023Dec 31, 2023-$2.10M–
Q1 FY2024CQ3 2023Sep 30, 2023-$5.75M–
Q4 FY2023CQ2 2023Jun 30, 2023-$2.58M–
Q3 FY2023CQ1 2023Mar 31, 2023-$2.73M–

More Incannex Healthcare figures

See a number that looks wrong?